Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yuichiro Nakamura
Pathological Roles of C‑Met in Bladder Cancer: Association With Cyclooxygenase‑2, Heme Oxygenase‑1, Vascular Endothelial Growth Factor‑A and Programmed Death Ligand�1
Oncology Letters
Cancer Research
Oncology
Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Differential Expression of Heme Oxygenase-1 and Vascular Endothelial Growth Factor in Cadaveric and Living Donor Kidneys After Ischemia-Reperfusion
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Cisplatin Contributes to Programmed Death-Ligand 1 (PD-L1) Expression in Bladder Cancer Through ERK1/2 - AP-1 Signaling Pathway
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Targeting Heme Oxygenase-1 in Vascular Disease
Current Drug Targets
Molecular Medicine
Drug Discovery
Clinical Biochemistry
Pharmacology
Fibroblast Growth Factor-1 Induces Heme Oxygenase-1 via Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) in Spinal Cord Astrocytes
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
S-Adenosyl Methionine Prevents Endothelial Dysfunction by Inducing Heme Oxygenase-1 in Vascular Endothelial Cells
Molecules and Cells
Medicine
Cell Biology
Molecular Biology
Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome
Archives of Rheumatology
Rheumatology
Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
Clinical Cancer Research
Cancer Research
Oncology
Clinicopathological Significance and Prognostic Implication of Programmed Death-1 Ligand 2 Expression in Colorectal Cancer
International Journal of Biological Markers
Oncology
Cancer Research
Clinical Biochemistry
Forensic Medicine
Medicine
Pathology
Predictive Role of Computed Tomography Texture Analysis in Patients With Metastatic Urothelial Cancer Treated With Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors
European urology oncology
Oncology
Radiology
Urology
Nuclear Medicine
Imaging
Surgery